Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Faruqi & Faruqi, LLP Securities Litigation Partners James (Josh) Wilson Urges Investors Suffering Losses Over $75,000 From Pacira To Contact Him Directly To Discuss Their Options.
If you have a loss of more than $75,000 per Pacira between August 2, 2023 and August 8, 2024 and you would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson live to 877-247-4292 or 212-983-9330 (Ext. 1310).
(You can also click here for more information)
New York, New York–(Newsfile Corp. – January 19, 2025) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pacira BioSciences, Inc . (“Pacira” or “Company” ) (NASDAQ: PCRX) and reminds investors of March 14, 2025 deadline seeking the role of lead plaintiff in a federal class action against the Company.
Faruqi & Faruqi is a leading national security law firm with offices in New York, Pennsylvania, California and Georgia. The firm has raised hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
According to the Complaint, on August 9, 2024, Pacira announced that the District Court of New Jersey had rejected its ‘495 patent, holding that eVenus did not infringe the ‘495 patent on the basis of obviousness and expectation. The complaint states that this decision came shortly after Pacira presented additional evidence to the Court, which the Court said would not have any impact on the basis of the decision. The complaint also states that this decision was the second of the same court’s decisions affecting the construction of Pacira’s ‘495 and ‘336 claims in favor of eVenus.
According to the complaint, Pacira’s announcement that its ‘495 patent was invalid surprised investors and analysts alike as they reacted immediately to the revelation. The protest means that the price of Pacira’s common stock has fallen significantly. According to the complaint, from a closing market price of $22.36 per share on August 8, 2024, Pacira’s stock price fell to a low of $11.70 per share on August 9, 2024, a drop of more than 47% per day and one, and thus destroy. investors.
The lead plaintiff appointed by the court is the investor with the greatest financial interest in the relief sought by a reasonable and common class of class members conducting and overseeing the case on behalf of the putative class. Any member of the arbitration panel may have the Court act as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent panel member. Your ability to participate in any recovery is not affected by the decision to serve as the lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information about Pacira’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Follow us for updates on LinkedIn, on X, or on Facebook (NASDAQ:).
Advertising Attorney. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Preliminary results do not guarantee or predict the same result with respect to any future issue. We welcome the opportunity to discuss your matter. All communications will be held confidentially.
To view the source version of this release, please visit https://www.newsfilecorp.com/release/237458
